Live Nation says it’s winning over casual fans, even as they grapple with higher prices
Even as executives elsewhere say high prices are still squeezing consumers, Ticketmaster parent Live Nation Entertainment…
Lemonade’s stock slides after digital insurer’s soft guidance offsets narrower-than-expected loss
Lemonade Inc.’s stock tumbled in after-hours trade Tuesday, after the digital insurer, which uses AI to…
Starbucks is trying to serve coffee faster and expand into smaller cities to turn business around
Starbucks Corp. on Tuesday reported quarterly sales that were worse than expected as the coffee chain…
A REIT-silient Quarter for my Famous 5 S-REITs Part II: MPACT and PLife
In my previous post, I shared my take on the latest earnings by Frasers Centrepoint Trust (SGX:…
Nvidia and Meta CEOs trade praise during AI tech-bro chat at graphics show
Jensen Huang and Mark Zuckerberg, the co-founders and CEOs of Nvidia Corp. and Meta Platforms Inc.,…
Japan’s labor-market tightness may keep adding to wage-growth pressure
Japan jobs data released Tuesday gave mixed signals but suggest that the relatively tight labor market…
F5 stock jumps after earnings beat, raised guidance
Shares of multi-cloud application services provider F5 climbed after the company’s fiscal third-quarter earnings beat analyst…
Cannabis company Tilray placed a huge bet on craft beers. It’s already paying off.
That bet appears to be paying off, with the company reporting better-than-expected quarterly sales late Monday,…
The owner of Bed Bath & Beyond and Overstock says it’s winning back customers, and shares are rallying
Shares of Beyond Inc., the company that owns Bed Bath & Beyond and Overstock, jumped after…
Sprouts Farmers Market says people are sticking with their diets despite higher food prices
Shares of Sprouts Farmers Market Inc. jumped after hours on Monday after the wellness-focused grocery chain…
Added More The Trade Desk and Veeva Systems
NASDAQ dropped by about 8% over the past fortnight. While such declines are not uncommon in…
Eisai stock slumps after Alzheimer’s drug fails to get approval in Europe
Eisai shares fell sharply after its Alzheimer’s drug failed to secure marketing approval in the European…